Queen Elizabeth Hospital is a hospital in Woolwich in the Royal Borough of Greenwich. It was opened in March 2001 and serves patients from the Royal Borough of Greenwich and the London Borough of Bexley.

There are 521 beds in Queen Elizabeth Hospital.

During the past decade, Queen Elizabeth Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Guy's and St Thomas' NHS Foundation Trust" with 2 trials sponsored, "King's College London" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Clinical Evaluation Research Unit at Kingston General Hospital" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 collaborator was "South London and Maudsley NHS Foundation Trust" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital" are "Breast Cancer" (3 trials), "Colorectal Cancer" (3 trials), "Breast Neoplasms" (1 trials), "Chronic Lymphocytic Leukaemia" (1 trials) and "Coronary Arteriosclerosis" (1 trials). Many other conditions were trialed in "Queen Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Hospital" are "Drug" (14 trials), "Other" (4 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "AZD2014" (1 trials), "Active Surveillance" (1 trials), "Aromatase Inhibitor" (1 trials), "Aromatase Inhibitors" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Hospital" are 17 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Queen Elizabeth Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Queen Elizabeth Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".